J. Goldman & Co »

Dyne Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $900k 46k 19.56

More positions owned by J. Goldman & Co

Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Honeywell International (HON)
Comcast Corp Cl A (CMCSA)
Western Union Company (WU)
Apple Call Option (AAPL)
Aramark Hldgs (ARMK)
Centuri Holdings Com Shs (CTRI)
Amazon (AMZN)
Gap (GAP)
eBay (EBAY)
Boeing Company (BA)
Sentinelone Cl A (S)
Verra Mobility Corp Cl A Com Stk (VRRM)

View all positions for J. Goldman & Co

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
State Street Corporation
Fcpm Iii Services B.v.
FMR
Orbis Allan Gray
TCG Crossover Management
Adage Capital Partners GP
Siren
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Dyne Therapeutics